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The purpose of this study was to evaluate the genotoxic potential of components leached from two 
conventional self-curing glass-ionomer cements (Fuji IX and Ketac Molar), and light-curing, resin modified 
glass-ionomer cements (Vitrebond, Fuji II LC). Evaluation was performed on human lymphocytes using 
alkaline and hOGG1 modified comet, and micronucleus assays. Each material, polymerised and 
unpolymerised, was eluted in extracellular saline (1 cm2 mL-1) for 1 h, 1 day, and 5 days. Cultures were 
treated with eluates using final dilutions of 10-2, 10-3, and 10-4. Alkaline comet assay did not detect changes 
in DNA migration of treated cells regardless of the ionomer tested, polymerisation state, and elution 
duration. Glass ionomers failed to significantly influence micronucleus frequency. No oxidative DNA 
damage in treated lymphocytes was observed using hOGG1 modified comet assay. Obtained results indicate 
high biocompatibility of all tested materials used in the study under experimental conditions.
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The most important requirement for a material to 
be used in medical applications is its biocompatibility. 
Dental materials can lead to cell damage of the pulp, 
gingiva, and oral mucosa. Various tests have been 
applied to assess the risk of such damage (1-4).
Due to their properties, glass ionomer cements 
(GICs) are widely used as restorative materials in 
dentistry. Since their commercial introduction, GICs 
have been available in essentially two types: 
‘conventional’ glass ionomers (CGICs) and resin-
modified glass ionomer cements (RMGICs) (5). 
C G I C s  a r e  c o m p o s e d  o f  f i n e  c a l c i u m 
fluoroaluminosilicate glass powder and aqueous 
solutions of polyacrylic acid and its copolymers. 
RMGICs are usually formulated from fluoro-
aluminosilicate glasses, photo-initiators, polyacrylic 
acid, water, and a water-soluble methacrylate 
monomer, such as hydroxyethyl methacrylate 
(HEMA) (6, 7). 
Despite the improved mechanical properties of 
RMGICs their biocompatibility is still controversial 
(4, 5). Most of the studies suggested that CGICs 
revealed minimal toxicity in vitro or in vivo, whereas 
RMGICs showed significant cytotoxicity and 
genotoxicity (8, 10-12). There are sufficient data 
demonstrating that the liberated substances may 
diffuse pulp ward in high quantities (triethyleneglycol-
dimethacrylate - TEGDMA, HEMA), particularly 
through thin dentin layers or after acid-etching of 
dentin. It appears that high quantities of these 
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components may result in pulpal inflammation (13). 
De Souza Costa et al. (10) reported that Vitrebond 
reduced viability of odontoblasts by 74.6 %, Fuji II 
LC by 45.5 %, Fuji IX by 29.5 %, and Ketac Molar 
by 32.5 %. However, Koulaouzidou et al. (14) found 
that Fuji II LC showed only minimal cytotoxicity and 
mild antiproliferative effect on three cell lines (L929, 
BHK21/C13, and RCP-C2A). Do Nascimento et al. 
(15) reported that Vitrebond could cause marked 
inflammatory pulpal reactions and a large necrotic 
zone. Six et al. (16) used Fuji IX on rats’ upper molars 
and found that after 8 days it caused disruption of the 
odontoblastic layer, blood vessels’ dilatation, and 
inflammatory reaction of the pulp with presence of 
bacteria in dentinal tubules. However, after 30 days, 
pulpal tissue was again healthy and looked normal 
(16). 
Thus, the aim of this in vitro study was to 
comparatively evaluate possible genotoxicity of 
monomers released from two types of commercially 
available groups of glass ionomers, CGICs and 
RMGICs, with respect to their polymerisation state 
and time elapsed from the setting of the materials. To 
detect possible differences in their mechanism of 
actions two different cytogenetic techniques were 
applied on human lymphocyte cultures: comet and 
micronucleus assay. In addition, human 8-oxoguanine 
glycosylase 1 (hOGG1) enzyme modified comet 




Each material was tested on lymphocytes of three 
young, healthy, non-smoking voluntary donors. The 
donors were one male and two females with mean age 
29.33±1.69. According to a questionnaire filled by 
donors, in 12 months prior to blood sampling, they 
had not been exposed to any physical or chemical 
agents that might have interfered with the results of 
genotoxicity testing. Blood was drawn by antecubital 
venipuncture into heparinised vacutainers (Becton 
Dickenson, Plymouth, UK). All donors were 
acquainted with the study and they willingly signed 
permissions to use their blood samples for scientific 
purposes. All described procedures were in accordance 
with the high ethical standards, complied with the 
principles laid down in the Declaration of Helsinki.  
Preparation of glass ionomer materials
Four different glass ionomers were tested: Fuji IX 
(GC Corp, Tokyo, Japan) and Ketac Molar (3M/ESPE, 
St. Paul, MN, USA) as conventional GICs, and Fuji 
II LC (GC Corp, Tokyo, Japan) and Vitrebond (3M/
ESPE, St. Paul, MN, USA) as resin-modified GICs. 
The composition of selected materials as per their 
manufacturers is presented in Table 1. Ionomers were 
polymerised in aseptic conditions as recommended 
by the manufacturers, in 4 mm in diameter and 2 mm 
thick rounded plates. CGICs were polymerised 
chemically in the air, and RMGICs with the Elipar 
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Table 1 Glass-ionomers used in the present study (according to manufacturers’ data sheets)
Glass ionomer group Ionomer tested Components
Resin-modified glass 
ionomer cements
Fuji II LC (GC, 
Tokyo, Japan)
Powder: fluoroaluminosilicate glass 
Liquid: polyacrylic acid and copolymer of acrylic and maleic acid, 
2-hydroxyethyl-methacrylate (HEMA), initiator, water.
Vitrebond (3M 
ESPE,  St. Paul, 
MN, USA)
Powder: SiO2, AlF3, ZnO, Na3AlF6, SP-940S glass powder, 
disodiumhydrogenphosphate, diphenyliodoniumchloride







Powder: fluoroaluminosilicate glass, polyacrylic acid powder
Liquid: polyacrylic acid, polybasic carboxylic acid
Ketac Molar
(3M ESPE, 
St. Paul, MN, 
USA)
Powder: fluoroaluminosilicate glass, ZnO, polycarboxylic acid, 
pigments
Liquid: water, copolymer acrylic calcium, maleic acid, tartaric acid, 
benzoic acid
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TriLight halogen curing unit (650 mW cm-2) from a 
distance of 2 mm for 40 s. Polymerised ionomers were 
eluted for 1 h, 1 day, and 5 days in extracellular saline 
(ECS), consisting of 40 mmol L-1 NaCl, 3 mmol L-1 
KCl, 1 mmol L-1 CaCl2, 1 mmol L
-1 MgCl2, 10 mmol L
-1 
HEPES, adjusted to pH 7.3–7.4 with NaOH. Material 
surface vs. ECS volume ratio was 1 cm2 mL-1 (17). 
The elutions of unpolymerised glass ionomers in ECS 
were set up in the same manner.
Initiation of cell cultures and micronucleus assay
To initiate the cell cultures, 0.5 mL of blood was 
introduced into a cell culture flask (Nunc GmbH, 
Wiesbaden, Germany) containing 5 mL of RPMI 
medium (Gibco, Carlsbad, USA) supplemented with 
15 % foetal bovine serum (Sigma, St. Louis, USA), 
10 μg mL-1 of phytohemagglutinin (Murex, Dartford, 
UK), 2.5 g L-1 of phenol red pH indicator (Sigma, St. 
Louis, USA), 100 IU of penicillin (Sigma, St. Louis, 
USA), and 100 IU of streptomycin (Sigma, St. Louis, 
USA). Duplicate cell cultures per donor were treated 
with the following four dilutions of each glass ionomer 
eluate: 10-1, 10-2, 10-3, and 10-4. Dilutions were 
prepared in RPMI medium, and pH values were 
adjusted at 7.2. The same treatment scheme was used 
for each of the three elution times (1 h, 1 day, and 5 
days). GIC eluates were initiated 5 days, 1 day, and 
1 h prior to blood sampling. The whole blood cultures 
were treated for 72 h. Simultaneously, negative control 
cultures were treated with the same volume of 
physiological solution of ECS, whereas the positive 
controls were treated with bleomycin (Sigma, St. 
Louis, USA) at the final concentration of 30 μg mL-1 
for the 5 last hours of cultivation. Cytochalasin B 
(Sigma, St. Louis, Germany) was added at a final 
concentration of 6 μg ml-1 to the cultures after 44 h of 
incubation. Cultures were incubated at 37 °C for 72 h. 
After incubation, the same culture was simultaneously 
subjected to analysis by all techniques.
For micronucleus assay, cells were centrifuged, 
pretreated with physiological solution, and fixed with 
3:1 (v/v) methanol/acetic acid solution. They were 
then air-dried and stained with 5 % Giemsa (Sigma, 
St. Louis, USA) (18). For each elution time and 
dilution tested, 1000 binucleated lymphocytes per 
duplicate slide per donor were analysed scoring the 
number of micronuclei. We applied the scoring criteria 
described by Fenech et al. (19).
Cytotoxicity testing
Using the trypan blue exclusion technique, the 
relative cell viability was tested 72 h after the cultures 
were initiated. For all tested ionomers, cytotoxicity of 
dilution 10-1 of 1-day eluates appeared to be higher 
than 17 %. Therefore, only the cultures treated with 
dilutions of 10-2, 10-3, and 10-4 were analysed using 
micronucleus, alkaline, and hOGG1 modified comet 
assays for all elution periods. After the treatment of 
cell cultures with ionomer eluates pH indicator 
contained within the medium did not show any 
changes in pH value. After the end of cultivation 
period, pH of each cell culture was additionally 
checked by a SevenEasy pH meter (Metler-Toledo 
GmbH, Schwertzenbach, Switzerland) and it was 
continuously 7.27±0.04, which is, according to the 
manufacturer, the regular pH value for RPMI cell 
culture medium.
Alkaline and hOGG1 modified comet assay
Following the treatment, cultures were centrifuged, 
supernatant removed, and both alkaline and hOGG1 
comet assays were performed on whole blood samples 
in accordance with the protocols by Singh et al. (20) 
and Smith et al. (21), respectively. All the chemicals 
were obtained from Sigma Chemical Company 
(Sigma-Aldrich, Munich, Germany).
Normal melting point agarose (NMP) 0.6 % was 
layered on slides precoated with 1 % NMP. Blood 
samples (8 µL) were mixed with 0.5 % low melting 
point agarose, placed on the slides, and immersed in 
standard ice-cold lysis solution (pH 10) and stored 
overnight at 4 °C. For the alkaline comet assay the 
standard procedure was followed (20). For the hOGG1 
modified comet assay, following the lysis slides were 
rinsed in three changes of neutralisation buffer 
(40 mmol L-1 HEPES, 0.1 mol L-1 KCl, 0.5 mmol L-1 
EDTA, pH 7.4) for 5 min at room temperature. One 
parallel slide was treated with hOGG1 enzyme in 
neutralisation buffer (V=60 µL; final dilution 1:1000). 
The other parallel slide was treated with 60 µL of 
neutralisation buffer only. Treatment was performed 
in a humidified chamber for 10 min at 37 °C and 
followed by 15 min of denaturation (1.5 mol L-1 NaCl, 
1 mmol L-1 Na2EDTA, pH 12.1) and 20 min of 
electrophoresis at 0.7 V cm-1, 300 mA. The slides were 
neutralised in three changes of buffer (0.4 mol L-1 
Tris-HCl, pH 7.5), 5 min each, stained with ethidium 
bromide (20 g mL-1) and examined using a 250x 
magnification fluorescence microscope (Olympus, 
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Japan). A total of 100 comets per concentration tested 
were scored on each duplicate slide. The edges of the 
gel, occasional dead cells, and superimposed comets 
were avoided. Tail length and tail intensity were 
measured using Comet Assay IV analysis system 
(Perceptive Instruments Ltd., Suffolk, UK). Oxidative 
DNA damage was calculated as per the following 
description. For each donor, mean tail intensity was 
calculated separately for the slides treated with 
hOGG1 enzyme and for the slides treated with buffer. 
Further difference between those two values was 
obtained for each donor, indicating oxidative DNA 
damage. Results of hOGG1 comet assay were 
presented as mean tail lengths only, since in this type 
of assay modification percentage of DNA in tail is the 
most informative parameter (21).
Statistical analysis
Differences in the number of micronuclei treated 
and control lymphocytes were evaluated using chi-
square and Fisher’s LSD test. Regarding the comet 
assay endpoints, to normalise the distribution and to 
equalise the variances, a logarithmic transformation 
of data was applied. Differences between the groups 
were tested using ANOVA followed by Duncan’s test. 
To evaluate oxidative DNA damage, differences 
between the means for the slides treated with enzyme 
and the corresponding slides treated with buffer only 
were tested using ANOVA followed by Duncan’s 
post-hoc analysis. The level of significance was set at 
0.05. 
RESULTS
Micronucleus assay did not show statistically 
increased micronucleus frequency for any of the 
eluates tested. A slightly increased number of 
micronuclei was detected in the cultures treated with 
10-2 dilution of 1-h eluates of unpolymerised Vitrebond 
and Ketac Molar (Figure 1). 
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Figure 1 Number of micronuclei in lymphocyte cultures treated with different dilutions (10-2, 10-3, and 10-4) of initial glass 
ionomer eluates (1 cm2 mL-1 of extracellular saline) after 1 h, 24 h, and 5 days of elution. One thousand binucleated lymphocytes 
were analysed per treatment on each of three blood samples
p - polymerised, n - unpolymerised
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Eluates of polymerised forms of these ionomers 
did not influence micronucleus frequency. Further, 
10-2 and 10-3 dilutions of 1-day eluates of unpolymerised 
Ketac Molar, and the polymerised form of GC Fuji II 
LC slightly, but insignificantly elevated the number 
of micronuclei (Figure 1). 
Similarly, in the culture treated with dose eluates, 
a slightly increased micronucleus frequency compared 
to 1-h elution was found. Dilution 10-2 of 5-day eluates 
of polymerised Vitrebond and GC Fuji IX GP, and 
unpolymerised Ketac Molar induced further 
insignificant elevation of MN (Figure 1). 
Neither did the comet assay show statistically 
increased tail length or Olive tail moment for any of 
the eluates of the tested glass ionomers, polymerised 
or unpolymerised. Again, slightly elevated DNA 
migration was detected in lymphocytes treated with 
10-2 dilution of 1-h of both unpolymerised and 
polymerised Vitrebond, unpolymerised Ketac Molar, 
and polymerised Fuji II LC (Figures 2, 3). Later 
eluates did not show any differences regardless of their 
dilution or polymerisation state.
Application of hOGG1 modified comet assay did 
not indicate an increase in the 8-oxoguanine formation 
due to possible oxidative stress induced by resin 
monomers released form the tested glass ionomers 
(Table 2). A slight increase in tail intensity was 
observed for all tested materials 24 h after the initial 
setting, and only for the lowest eluate dilution (10-2). 
However, the increase was simultaneously observed 
for the slides treated with hOGG1 enzyme and the 
corresponding buffer treated slides. We did not observe 
any statistical difference in the percentage of DNA in 
tails due to hOGG1 treatment.
DISCUSSION
The study presents the results of genotoxicity 
evaluation of eluates of four glass ionomers: Fuji II 
LC and Vitrebond as resin-modified glass ionomer 
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Figure 2 Tail length values for lymphocyte cultures treated with different dilutions (10-2, 10-3, and 10-4) of initial glass ionomer 
eluates (1 cm2 mL-1 of extracellular saline) after 1 h, 24 h, and 5 days of elution. One hundred comets were analysed per treatment 
on each of three blood samples. 
p - polymerised, n - unpolymerised
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cements, and Fuji IX and Ketac Molar as conventional 
glass ionomer cements. We aimed to detect possible 
differences in the mechanisms of their genotoxicity 
that may arise due to differences in their composition 
and initiation of polymerisation (chemical or 
photoactivation). To get more information on their 
biocompatibility, glass ionomer cements were tested 
both in their unpolymerised and polymerised form. In 
this assessment two cytogenetic techniques were used: 
alkaline comet and micronucleus assay. Comet assay 
detects primary DNA damage that could result from 
direct interaction of monomers, initiators or any other 
leached components with genomic DNA. That type 
of damage does not require cell division to be 
expressed and evaluated (22). Modification of the 
comet assay procedure by exposing the isolated DNA 
to hOGG1 enzyme allows to specifically detect 
8-oxoguanine base that arises as a result of oxidative 
DNA damage. Micronucleus assay detects DNA 
lesions that are not repaired properly and after 
replication result in the formation of acentric 
chromosome fragments. It also detects damage of the 
cell spindle disabling chromosomes to be attached 
properly and chromatids to be divided between the 
newly forming cells. Thus, contrary to the comet assay, 
micronucleus assay enables detection of both types of 
genotoxic agents, clastogens and aneugens (18). 
It has been proven that due to incomplete 
polymerisation, residual monomers (HEMA, Bis-
GMA) are leached from dental materials (23). In our 
study we did not detect any genome damage in the 
above mentioned period of time and eluate dilutions 
using comet assay. However, micronucleus assay 
indicated a slight but insignificant increase in the 
micronucleus frequency in lymphocytes treated with 
the lowest dilution (10-2) of 1-day eluate of polymerised 
GC Fuji II LC, and 5-day eluates of polymerised 
Vitrebond and GC Fuji IX GP. Unpolymerised 
Vitrebond and Ketac Molar insignificantly elevated 
micronuclei incidence as early as after 1-h elution 
indicating faster leaching of active components from 
unpolymerised materials. Unpolymerised Ketac Molar 
slightly influenced micronuclei induction throughout 
the entire period of 5-day elution indicating persistence 
of its leached active components, presumably ZnO 
that was suspected to be clastogenic and that was not 
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Figure 3 Mean tail moment values for lymphocyte cultures treated with different dilutions (10-2, 10-3, and 10-4) of initial glass 
ionomer eluates (1 cm2 mL-1 of extracellular saline) after 1 h, 24 h, and 5 days of elution. One hundred comets were analysed 
per treatment on each of three blood samples. 
p - polymerised, n - unpolymerised
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contained in other glass-ionomers (24). However, the 
observed effects could not at all be considered 
biologically relevant. Considering the effect of 
Vitrebond and Fuji II LC on micronucleus frequency, 
it would be mainly mediated by HEMA that is known 
to be genotoxic (25). Contrary to Kleinsasser et al. 
(25) that reported increased DNA migration ability of 
human lymphocytes exposed to HEMA, we did not 
detect any effect of ionomers containing this monomer 
on comet assay endpoints. Thus, the observed 
fluctuations in the number of micronuclei, although 
biologically insignificant, might have been mediated 
by slight anuegenic effect of monomers. Vitrebond’s 
genotoxicity could be additionally mediated by 
dipheniliodiumchloride (DPICI) that is used as the 
initiator. Leyhausen et al. (26) reported that DPICI 
that was leached from polymerised Vitrebond 
exhibited genotoxic activity. These results may 
suggest that even from the unpolymerised form of 
ionomers, after mixing powder and liquid components 
HEMA could not be leached in the amounts needed 
to induce significant DNA damage under the 
experimental conditions used in our evaluation. The 
choice of solvent vehicle used in elution might also 
be critical. Kleinsasser et al. (25) used organic solvent 
DMSO, and we used extracellular saline as the main 
polar solvent saline solution. Ribeiro et al. (27) 
published the results on genotoxic evaluations of 
Vitrebond and Ketac Molar on Chinese hamster ovary 
(CHO) and mouse lymphoma (L5178Y) cell lines 
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Table 2 Results of hOGG1 modified comet assay presenting mean tail intensity values (% DNA in comet’s tail). The results 
obtained for the slides treated with buffer and the corresponding slides treated with enzyme are shown for each treatment. One 
hundred comets were analysed per treatment on each of three blood samples
Glass ionomer Form Eluate dilution
Oxidative DNA damage after elution of glass 
ionomers (mean±SD)
1 h 1 day 5 days
Vitrebond
Unpolymerised
10-2 0.70±0.32 1.98±0.94 0.12±0.06
10-3 0.16±0.08 1.86±0.98 0.08±0.02
10-4 0.14±0.06 1.02±0.86 0.06±0.00
Polymerised
10-2 0.18±0.08 1.18±0.80 0.05±0.03
10-3 0.12±0.04 1.33±0.82 0.06±0.01
10-4 0.24±0.07 0.92±0.47 0.04±0.01
Ketac Molar
Unpolymerised
10-2 0.16±0.03 1.53±0.68 0.34±0.11
10-3 0.02±0.00 0.95±0.23 0.13±0.05
10-4 0.03±0.01 1.31±0.54 0.11±0.01
Polymerised
10-2 0.27±0.09 1.40±0.86 0.16±0.03
10-3 0.04±0.00 0.90±0.32 0.22±0.08
10-4 0.14±0.05 0.13±0.06 0.18±0.06
GC Fuji IX GP
Unpolymerised
10-2 0.01±0.00 1.52±0.27 0.18±0.03
10-3 0.14±0.02 1.07±0.09 0.24±0.09
10-4 0.07±0.05 0.86±0.14 0.06±0.02
Polymerised
10-2 0.14±0.04 0.97±0.07 0.11±0.03
10-3 0.15±0.04 1.13±0.74 0.14±0.02
10-4 0.01±0.01 0.98±0.55 0.12±0.02
GC Fuji II LC
Unpolymerised
10-2 0.13±0.05 0.93±0.28 0.01±0.02
10-3 0.09±0.03 1.20±0.23 0.14±0.03
10-4 0.08±0.03 0.87±0.17 0.12±0.03
Polymerised
10-2 0.11±0.03 1.04±0.19 0.14±0.03
10-3 0.02±0.01 1.17±0.41 0.10±0.02
10-4 0.04±0.03 0.92±0.47 0.11±0.02
Negative control (22 μL extracellular saline) 0.02±0.02 0.81±0.18 0.03±0.01
Positive control (0.1 mmol L-1 H2O2 10 min) 16.4±1.82
1 28.07±1.201 15.7±1.051
1statistically significant oxidative DNA damage, p<0.05 between the corresponding slides treated with hOGG1 enzyme and 
buffer only. Oxidative DNA damage was calculated as difference in tail intensity values between hOGG1 and buffer treated 
slides.
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using comet assay. Unlike in our study, they tested the 
components separately without mixing them. The 
results showed that powders from assay did not show 
genotoxic effects. The authors observed increased 
DNA migration only for the highest concentration of 
Ketac Molar powder phase (100 µg mL-1 and 
1000 µg mL-1), and the highest concentration of 
Vitrebond liquid phase (1 %). No measurable 
genotoxicity was found in the liquid from Ketac Molar 
in all dilutions tested (0.01–1 %). In the study of 
Bakopoulou et al. (28), 72 h-eluates of Ketac Cem 
significantly increased the frequency of sister 
chromatid exchanges and chromosomal aberrations 
in human lymphocyte cultures.
Stea et al. (29) evaluated genotoxicity of Vitrebond 
eluates in human lymphocytes cultures using sister 
chromatid exchange (SCE) assay. The authors reported 
increased SCE frequency for 10-2 eluate dilution of 
unpolymerised Vitrebond and 10-1 of the polymerised 
one. Bakopoulou et al. (28) showed Vitrebond’s eluate 
to be very cytotoxic, as the first series of dilutions of 
both materials caused a complete mitotic arrest in 
lymphocyte cultures but the authors used ten-fold 
lower dilutions of eluate in culture treatment than we 
did in the present study. Also, the eluate derived from 
Vitrebond specimens (5 mm in diameter and 2 mm 
thick) caused extensive genotoxicity after 24 h, 
increasing the frequencies of sister chromatid 
exchange and the number of chromosomal aberrations 
(28). Of all the observed insignificant effects on 
micronucleus frequency, the one caused by Fuji IX 
was the lowest.
The main deficiency of ex vivo tests is their 
questionable clinical relevance. Although the effects 
detected in in vitro studies could not be directly 
extrapolated into in vivo conditions, they are 
informative and could indicate a potential degree of 
health risk that may arise from using certain chemical 
compounds in dental restoration. In vitro studies 
provide limited responses due to the lack of biological 
and physiological components that cannot be 
replicated in the laboratory. The largest limitations of 
this study were low concentrations used to reproduce 
the situation in the mouth and the type of cell on which 
we carried out the research. It would have been a better 
solution to have used oral cells that are the first line 
of defence in the oral cavity in direct contact with the 
tested material. We could suggest that under the 
conditions presented in this study, in non-toxic 
concentrations range, the evaluated glass ionomer 
cements (Vitrebond, Ketac Molar, Fuji IX GP, and 
Fuji II LC) did not exhibit any biologically relevant 
genotoxic activity on peripheral blood lymphocytes 
in vitro measured by comet and micronucleus assays, 
nor were they able to induce oxidative DNA damage. 
With respect to such results, a slight and insignificant 
increase in the micronucleus number might raise 
suspicion of their restricted aneugenicity. Altogether, 
under the experimental conditions used in the study, 
the tested glass ionomers showed a satisfying level of 
biocompatibility.
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Sažetak 
Procjena in vitro toksičnosti stakleno-ionomernih cemenata primjenom mikronukleus testa, alkalnog 
komet testa i komet testa modificiranog hOGG1 enzimom 
Svrha istraživanja bila je procijeniti genotoksični potencijal komponenata koje izlučuju dva konvencionalna 
samopolimerizirajuća stakleno-ionomerna cementa (Fuji IX i Ketac Molar) te svjetlosno polimerizirajući 
i smolom modificirani stakleno-ionomerni cementi (Vitrebond, Fuji II LC). Istraživanje je provedeno na 
ljudskim limfocitima primjenom alkalnog komet testa, komet testa modificiranog hOGG1 enzimom te 
mikronukleus testa. Svaki materijal, polimerizirani i nepolimerizirani, eluiran je u fiziološkoj otopini 
(1 cm2 mL-1) tijekom jednog sata, jednog dana i tijekom 5 dana. Kulture limfocita tretirane su eluatima u 
razrjeđenjima 10-2, 10-3 i 10-4. Alkalnim komet testom nisu zabilježene promjene u migraciji DNA iz 
tretiranih stanica bez obzira na ispitani ionomer, vrstu polimerizacije i trajanje elucije. Izloženost staklenim 
ionomerima nije značajno utjecala na učestalost mikronukleusa. Primjenom hOGG1 modificiranog komet 
testa nije zamijećeno oksidativno oštećenje DNA u tretiranim limfocitima. Dobiveni rezultati upućuju na 
visoki stupanj biokompatibilnosti svih testiranih materijala koji su se koristili u eksperimentalnim uvjetima. 
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